We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01396408
Recruitment Status : Active, not recruiting
First Posted : July 18, 2011
Last Update Posted : March 28, 2017
Sponsor:
Information provided by (Responsible Party):
Canadian Cancer Trials Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : July 2015
  Estimated Study Completion Date : December 2017